DOCDATA Financials
| DOC2 Stock | EUR 0.42 0.00 0.00% |
Historical analysis of DOCDATA income statement accounts such as Interest Income of 126.8 K or Interest Expense of 0.0 can show how well DOCDATA performed in making a profits. Evaluating DOCDATA income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DOCDATA's future profits or losses.
DOCDATA Income Statement Account Activities
Interest Income is advancing compared to historical levels. DOCDATA reported 120,750 in Interest Income for the previous period. As of March 13th, 2026, Total Revenue is estimated to rise to approximately 3.5 M, whereas Net Loss is moving lower toward about -758.8 K.Key indicators impacting DOCDATA's financial strength
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Net Receivables | 19.7 K | 20.7 K |
|
| |||||
| Total Revenue | 3.5 M | 3.3 M |
|
| |||||
| Total Assets | 4.8 M | 9.4 M |
|
|
DOCDATA | Select Account or Indicator |
Tracking DOCDATA's key financial metrics over multiple periods helps investors identify inflection points in growth, profitability, or leverage before they become apparent in DOCDATA's stock price.
The reliability of DOCDATA's financial statements depends on the integrity of management and the diligence of external auditors. Verify DOCDATA's earnings quality using forensic accounting tools available on this platform.
DOCDATA Stock Summary
DOCDATA competes with Australian Agricultural, J+J SNACK, Daito Trust, Titan Machinery, and Agricultural Bank. DOCDATA maintains listing status on the Berlin Exchange exchange.Specialization | Materials, Materials |
| Instrument | Germany Stock View All |
| Exchange | Berlin Exchange |
| Sector | Metals & Mining |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Currency | EUR - Euro |
You should never invest in DOCDATA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of DOCDATA Stock, because this is throwing your money away. Analyzing the key information contained in DOCDATA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Key Financial Ratios
There are many critical financial ratios that DOCDATA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that DOCDATA reports annually and quarterly.| Total Asset | 8.13 M | |||
| Retained Earnings | -32.89 M |
Key Balance Sheet Accounts
DOCDATA holds 3.2 M in cash and equivalents, a figure that shapes the company's ability to invest, acquire, or weather downturns. Reviewing the full balance sheet adds context to that headline number and reveals the broader financial picture.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Total Assets | 2.2M | 11.0M | 9.7M | 8.1M | 9.4M | 4.8M | |
| Retained Earnings | -4.4M | -31.2M | -32.1M | -32.9M | -29.6M | -28.1M | |
| Accounts Payable | 100K | 90K | 60K | 36K | 32.4K | 30.8K | |
| Cash | 2K | 3.4M | 2.7M | 2.7M | 3.1M | 3.2M | |
| Total Liab | 1.3M | 2.8M | 2.3M | 1.6M | 1.9M | 1.4M | |
| Total Current Assets | 371K | 5.4M | 5.0M | 4.3M | 4.9M | 5.1M | |
| Net Invested Capital | 1.4M | 8.2M | 7.3M | 6.5M | 7.5M | 4.1M | |
| Net Working Capital | -897K | 3.2M | 2.6M | 2.6M | 3.0M | 3.2M | |
| Intangible Assets | 1.8M | 3.9M | 3.2M | 2.5M | 2.9M | 2.4M | |
| Other Current Liab | 253K | 999K | 484K | 188K | 216.2K | 339.9K | |
| Net Receivables | 352K | 1.0M | 338K | 18K | 20.7K | 19.7K |
Key Cash Accounts
A company that consistently converts profits into cash is one that investors can trust. DOCDATA's operating cash flow anchors that assessment. The detailed cash accounts below show how that cash is generated and deployed.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Investments | -671K | 99K | -11K | -131K | -150.7K | -158.2K | |
| Change In Cash | 2K | 3.4M | -709K | 3K | 3.5K | 3.6K | |
| Depreciation | 211K | 24.6M | 899K | 954K | 1.1M | 1.0M | |
| Total Cash From Operating Activities | -448K | -2.7M | -698K | 134K | 154.1K | 161.8K | |
| Net Income | -808K | -26.8M | -1.5M | -803K | -722.7K | -758.8K | |
| End Period Cash Flow | 2K | 3.4M | 2.7M | 2.7M | 3.1M | 3.2M | |
| Free Cash Flow | -448K | -2.7M | -709K | 3K | 2.7K | 2.8K | |
| Change In Working Capital | 167K | -894K | -112K | -18K | -16.2K | -17.0K | |
| Other Non Cash Items | 10K | 23K | -41K | -105K | -94.5K | -89.8K |
Financial Ratios Relationships
Comparative valuation applies peer-based financial ratios to assess DOCDATA's relative market value. You can analyze the relationship between different fundamental ratios across DOCDATA competition to find correlations between indicators driving DOCDATA's intrinsic value. More Info.DOCDATA leads all stocks for current valuation relative to top peers. It holds the #2 position for price to book relative to top peers . The Current Valuation to Price To Book ratio for DOCDATA comes in at 3,971,085 . Peer multiple benchmarking positions DOCDATA within its competitive valuation range.Total Assets Over Time
Core Fundamental Drivers
Most income statement accounts are closely connected. Combined analysis offers stronger insight into DOCDATA's financial health. DOCDATA has a market cap of 30.91 M. Use Investing Opportunities to explore allocation context. This includes a position in DOCDATA in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. Interest Income is advancing compared to historical levels. DOCDATA reported 120,750 in Interest Income for the previous period. As of March 13th, 2026, Total Revenue is estimated to rise to approximately 3.5 M, whereas Net Loss is moving lower toward about -758.8 K.
Financial Account Correlations
Click cells to compare fundamentals
Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Financial Metrics, Fundamentals & Methodology
A detailed fundamental review of DOCDATA evaluates revenue consistency, margin structure, and capital efficiency. Balance-sheet composition highlights financial flexibility and solvency profile.
This section for DOCDATA is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Accounting-line values follow GAAP or IFRS structures as published in issuer filings.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardPopular Tools for DOCDATA Stock analysis
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |